SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin

05/10/2021 07:26
BRIEF-Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin

- Fortress Biotech Inc FBIO.O:

  • FORTRESS BIOTECH ANNOUNCES EXCLUSIVE LICENSE AGREEMENT WITH FUJI YAKUHIN TO DEVELOP DOTINURAD IN NORTH AMERICA AND EUROPE

  • FORTRESS BIOTECH INC - FUJI IS ELIGIBLE TO RECEIVE UPFRONT, DEVELOPMENT AND COMMERCIAL MILESTONE AND ROYALTY PAYMENTS FROM COMPANY.

  • FORTRESS BIOTECH - EXPECTS TO LEVERAGE DATA FROM 3 COMPLETED PHASE 3 CLINICAL TRIALS IN MORE THAN 500 JAPANESE PATIENTS TO DEVELOP AND MARKET DOTINURAD.

Source text for Eikon: ID:nGNX9Q02Xy

Further company coverage: FBIO.O


(([email protected];))